Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Laryngeal Diseases 1

Interventions

Cisplatin 8Radiotherapy 4Pemetrexed 4Cetuximab 4Gemcitabine 3Gefitinib 2Fluorouracil 2Drug Therapy 2Docetaxel 2Carboplatin 2pembrolizumab 1X-Rays 1Vitamin B 12 1Tirapazamine 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Paclitaxel 1Nivolumab 1Nimorazole 1Narrow Band Imaging 1Metformin 1MLN 8237 1LY2940680 1Ipilimumab 1Hydroxyurea 1Gabapentin 1Folic Acid 1Fibroblast Growth Factor 7 1Chemical Fractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Laryngeal Diseases × Nimorazole × Clear all
NCT01733823 2017-07-28

DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole

Danish Head and Neck Cancer Group

Phase 1/2 Completed
31 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡